| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.097 | 0.02 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |